Chattem Sales Up 51% Behind Ongoing Push From J&J Acquisitions
This article was originally published in The Tan Sheet
Executive Summary
Brands Chattem acquired from Johnson & Johnson and continued growth of its own Gold Bond and Icy Hot drove a 51 percent increase in third-quarter revenues, the firm reported Sept. 27
You may also be interested in...
Chattem To Revive Rolaids Line Bought From J&J
Chattem snaps up Rolaids from Johnson & Johnson subsidiary McNeil, which never restocked the iconic heartburn relief brand after recalling and suspending production in 2010. Sanofi touts Rolaids as “an enduring brand with a deep heritage.”
Chattem To Revive Rolaids Line Bought From J&J
Chattem snaps up Rolaids from Johnson & Johnson subsidiary McNeil, which never restocked the iconic heartburn relief brand after recalling and suspending production in 2010. Sanofi touts Rolaids as “an enduring brand with a deep heritage.”
Chattem’s Dexatrim Looks For Cost-Conscious Consumers Unfriendly To Alli
Chattem has not delivered a counter-punch to GlaxoSmithKline's alli, but the firm sees its Dexatrim supplement as "the only one left standing" to compete in the nonprescription weight-loss product category